Home treatment
 

Keywords :   


Tag: treatment

Single-Dose, Injected Flu Treatment Shows Promise

2014-09-06 23:32:37| Biotech - Topix.net

The studies included a total of 427 adults who were given one injection of the drug peramivir or a placebo within 48 hours of the start of flu symptoms. Compared to those given the "dummy" injection, patients who received the drug were symptom-free a median of 22 hours sooner, and fever-free 24 hours sooner, the studies found.

Tags: shows treatment promise flu

 

Seepex Webinar Covers Pumps For Water Treatment

2014-09-06 02:15:00| Chemical Processing

Seepex will conduct a webinar on how progressing cavity pumps are used in water treatment plants.

Tags: water treatment covers pumps

 
 

Cerenis Receives EMA Orphan Drug Designations For CER-001 For The Treatment Of ApoA-I And ABCA-1 Deficiencies

2014-09-03 12:18:47| drugdiscoveryonline Home Page

Cerenis Therapeutics, the biopharmaceutical company developing CER-001, an engineered human apoA-I-containing pre-beta HDL mimetic, for the treatment of cardiovascular disease, recently announced that it has received two separate Orphan Drug Designations from the European Medicines Agency (EMA) for the use of CER-001 in the treatment of patients with rare genetic defects in HDL synthesis/maturation pathways, specifically apoA-I deficiency and ABCA1 deficiency

Tags: treatment drug receives deficiencies

 

BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting

2014-09-02 15:31:04| Biotech - Topix.net

BioCryst Pharmaceuticals, Inc. today announced the presentation of trial results related to intravenous peramivir for the treatment of influenza at the Interscience Conference on Antimicrobial Agents & Chemotherapy in Washington, D.C., September 5-9, 2014.

Tags: the results present meeting

 

MediciNova to Present Data on MN-001 (tipelukast) for the Treatment...

2014-09-02 04:24:52| Biotech - Topix.net

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced that it will present at the 18th International Colloquium on Lung and Airway Fibrosis to be held this September in Mont Tremblant, Quebec, Canada.

Tags: the data present treatment

 

Sites : [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] next »